P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000971548.82531.93 |
| _version_ | 1797281602664923136 |
|---|---|
| author | Xiyuan Zhang Kang Chen Hui Wang Xiuizhi Deng Guoqiang Liu Junjie MA Juan Wang Xianghua Wang Zhenhui LV Zengjun LI Ling Wang |
| author_facet | Xiyuan Zhang Kang Chen Hui Wang Xiuizhi Deng Guoqiang Liu Junjie MA Juan Wang Xianghua Wang Zhenhui LV Zengjun LI Ling Wang |
| author_sort | Xiyuan Zhang |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:59:48Z |
| format | Article |
| id | doaj.art-356ca78b8f2940c083e668369bb08685 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:59:48Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-356ca78b8f2940c083e668369bb086852024-03-03T03:25:31ZengWileyHemaSphere2572-92412023-08-017e825319310.1097/01.HS9.0000971548.82531.93202308003-01061P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMAXiyuan Zhang0Kang Chen1Hui Wang2Xiuizhi Deng3Guoqiang Liu4Junjie MA5Juan Wang6Xianghua Wang7Zhenhui LV8Zengjun LI9Ling Wang101 Qingdao Central Hospital of Qingdao University, The Second Affiliated Hospital of Medical College of Qingdao University, Department of Hematology, China1 Qingdao Central Hospital of Qingdao University, The Second Affiliated Hospital of Medical College of Qingdao University, Department of Hematology, China2 Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Hematology, China3 Weihai Municipal Hospital, Department of Hematology, China4 Shengli Oilfield Central Hospital, Department of Hematology, China5 The affiliated Yantai Yuhuangding Hospital of Qingdao University, Department of Hematology, China6 Shandong Qilu Hospital (Qingdao Branch), Department of Hematology, China7 Shandong Provincial Hospital Affiliated to Shandong First Medical University, Department of Hematology, China8 Zibo Central Hospital, Department of Hematology, China2 Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Hematology, China1 Qingdao Central Hospital of Qingdao University, The Second Affiliated Hospital of Medical College of Qingdao University, Department of Hematology, Chinahttp://journals.lww.com/10.1097/01.HS9.0000971548.82531.93 |
| spellingShingle | Xiyuan Zhang Kang Chen Hui Wang Xiuizhi Deng Guoqiang Liu Junjie MA Juan Wang Xianghua Wang Zhenhui LV Zengjun LI Ling Wang P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA HemaSphere |
| title | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_fullStr | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_full_unstemmed | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_short | P1163: ZANUBRUTINIB PLUS RITUXIMAB AND LENALIDOMIDE (ZR2) FOR RELAPSED AND REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA |
| title_sort | p1163 zanubrutinib plus rituximab and lenalidomide zr2 for relapsed and refractory diffuse large b cell lymphoma |
| url | http://journals.lww.com/10.1097/01.HS9.0000971548.82531.93 |
| work_keys_str_mv | AT xiyuanzhang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT kangchen p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT huiwang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT xiuizhideng p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT guoqiangliu p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT junjiema p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT juanwang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT xianghuawang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT zhenhuilv p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT zengjunli p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma AT lingwang p1163zanubrutinibplusrituximabandlenalidomidezr2forrelapsedandrefractorydiffuselargebcelllymphoma |